Dopamine receptor blockade and the neuroleptics, a crystallographic study.
The X-ray structures of 12 drugs of the tricyclic class having varying pharmacological profiles have been examined in detail in an attempt to rationalize the known structure-activity relations of neuroleptic drugs with respect to their ability to block dopamine receptors in the brain. Further evidence is presented in support of the theory that the neuroleptics are able to block dopamine receptors because of a conformational complementarity between certain portions of these drugs and dopamine.
D002746:Chlorpromazine / Q000494:pharmacology; D002749:Chlorprothixene / Q000494:pharmacology; D003461:Crystallography; D018492:Dopamine Antagonists; D005475:Flupenthixol / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D008968:Molecular Conformation; D010640:Phenothiazines / Q000494:pharmacology; D011395:Promazine / Q000494:pharmacology; D011398:Promethazine / Q000494:pharmacology; D011955:Receptors, Drug; D013329:Structure-Activity Relationship; D013847:Thiethylperazine / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014273:Triflupromazine / Q000494:pharmacology
D018492:Dopamine Antagonists; D010640:Phenothiazines; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D013847:Thiethylperazine; D002749:Chlorprothixene; D005475:Flupenthixol; D011398:Promethazine; D011395:Promazine; D007099:Imipramine; D014273:Triflupromazine; D002746:Chlorpromazine